Il rapporto
Notizie verificate su finanziamenti, sedi centrali e leadership delle aziende più innovative al mondo
4 report e oltre
Abcuro Raises $66M Series D for Inclusion Body Myositis Trial
Abcuro raised a $66 million Series D led by New Leaf Venture Partners to fund a new potentially registrational study of ulviprubart in inclusion body myositis.
Abcuro Raises $200M in Series C
Abcuro, a HealthTech company based in Cambridge, MA, has raised $200M in Series C at a $1.5B valuation led by RA Capital, Arch Venture Partners.
Abcuro raises $200M Series C at $1.5B valuation
Abcuro raises $200M in Series C at $1.5B valuation. Antibody therapeutics for autoimmune diseases...
Abcuro Raises $200M Series C to Transform Biotech
Abcuro has secured $200M Series C in funding to accelerate growth and innovation in the biotech sector. Precision oncology company discovering and developing novel cancer immunotherapies targeting tumor microenvironments...
Visualizzazione di 4 report • Pagina 1 • Categoria: all
Rimani avanti rispetto al mercato
Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.



